These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11071270)

  • 1. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays.
    Martoglio AM; Tom BD; Starkey M; Corps AN; Charnock-Jones DS; Smith SK
    Mol Med; 2000 Sep; 6(9):750-65. PubMed ID: 11071270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.
    Welsh JB; Zarrinkar PP; Sapinoso LM; Kern SG; Behling CA; Monk BJ; Lockhart DJ; Burger RA; Hampton GM
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1176-81. PubMed ID: 11158614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
    Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
    Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.
    Schummer M; Ng WV; Bumgarner RE; Nelson PS; Schummer B; Bednarski DW; Hassell L; Baldwin RL; Karlan BY; Hood L
    Gene; 1999 Oct; 238(2):375-85. PubMed ID: 10570965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.
    Vecchione A; Belletti B; Lovat F; Volinia S; Chiappetta G; Giglio S; Sonego M; Cirombella R; Onesti EC; Pellegrini P; Califano D; Pignata S; Losito S; Canzonieri V; Sorio R; Alder H; Wernicke D; Stoppacciaro A; Baldassarre G; Croce CM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9845-50. PubMed ID: 23697367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling of selected angiogenesis-related genes in serous ovarian cancer patients.
    Kuć P; Charkiewicz R; Klasa-Mazurkiewicz D; Milczek T; Mroczko B; Nikliński J; Laudański P
    Adv Med Sci; 2017 Mar; 62(1):116-120. PubMed ID: 28235714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of alternative probe synthesis approaches for gene expression profiling with arrays.
    Vernon SD; Unger ER; Rajeevan M; Dimulescu IM; Nisenbaum R; Campbell CE
    J Mol Diagn; 2000 Aug; 2(3):124-7. PubMed ID: 11229515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
    Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
    Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array.
    Chen KT; Lin JD; Chao TC; Hsueh C; Chang CA; Weng HF; Chan EC
    Thyroid; 2001 Jan; 11(1):41-6. PubMed ID: 11272096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.
    Yoneda J; Kuniyasu H; Crispens MA; Price JE; Bucana CD; Fidler IJ
    J Natl Cancer Inst; 1998 Mar; 90(6):447-54. PubMed ID: 9521169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes.
    Mendiola M; Redondo A; Heredia-Soto V; Herranz J; Berjón A; Hernández A; Miguel-Martín M; Crespo R; Barriuso J; Cruz P; Yébenes L; Peláez-García A; Castelo B; DE Molina AR; Feliu J; Hardisson D
    Anticancer Res; 2018 Sep; 38(9):5393-5400. PubMed ID: 30194194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis.
    Chaib H; Cockrell EK; Rubin MA; Macoska JA
    Neoplasia; 2001; 3(1):43-52. PubMed ID: 11326315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in gene expression during progression of ovarian carcinoma.
    Tapper J; Kettunen E; El-Rifai W; Seppälä M; Andersson LC; Knuutila S
    Cancer Genet Cytogenet; 2001 Jul; 128(1):1-6. PubMed ID: 11454421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.
    Jazaeri AA; Yee CJ; Sotiriou C; Brantley KR; Boyd J; Liu ET
    J Natl Cancer Inst; 2002 Jul; 94(13):990-1000. PubMed ID: 12096084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
    Birrer MJ; Johnson ME; Hao K; Wong KK; Park DC; Bell A; Welch WR; Berkowitz RS; Mok SC
    J Clin Oncol; 2007 Jun; 25(16):2281-7. PubMed ID: 17538174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway.
    Dong G; Loukinova E; Chen Z; Gangi L; Chanturita TI; Liu ET; Van Waes C
    Cancer Res; 2001 Jun; 61(12):4797-808. PubMed ID: 11406555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
    Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
    J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
    Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
    Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.